Home › Stock analysis › NUS
Nu Skin Enterprises (NUS) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
What changed since yesterday
- Closed at $5.14, -1.34% vs the prior close of $5.21.
- Volume 572.31K shares, 1.0x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
NUS dips 1.3% to $5.14. Closed at $5.14, -1.34% vs the prior close of $5.21. Day range $5.11–$5.39, opened at $5.24.
Last close$5.14-1.34%
Day range5.11–5.39
Open5.24
Volume572.31K
52-week range4.45–11.67
Avg volume (20d)480.26K
NUS daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — NUS dips 1.3% to $5.14
- Closed at $5.14, -1.34% vs the prior close of $5.21. Day range $5.11–$5.39, opened at $5.24.
- Volume was 572.31K shares, 1.0x its 50-day average of 560.48K.
- Price is +7.4% vs its 50-day average ($4.79) and -22.9% vs its 200-day average ($6.66).
- 52-week range $4.45–$11.67; today's close sits at 10% of that range, 56.0% below the 52-week high.
Oct 15, 2026 — NUS rises 2.0% to $5.21, a 1-month high, 4 up days in a row
- Closed at $5.21, +1.96% vs the prior close of $5.11. Day range $5.16–$5.34, opened at $5.16.
- Volume was 511.40K shares, 0.9x its 50-day average of 559.23K.
- Price is +8.8% vs its 50-day average ($4.79) and -22.1% vs its 200-day average ($6.69).
- 52-week range $4.45–$11.67; today's close sits at 11% of that range, 55.4% below the 52-week high.
- That makes 4 straight gains.
Oct 14, 2026 — NUS rises 2.0% to $5.11, a 1-month high, 3 up days in a row
- Closed at $5.11, +2.00% vs the prior close of $5.01. Day range $4.99–$5.12, opened at $5.03.
- Volume was 421.40K shares, 0.7x its 50-day average of 563.19K.
- Price is +6.7% vs its 50-day average ($4.79) and -23.8% vs its 200-day average ($6.71).
- 52-week range $4.45–$11.67; today's close sits at 9% of that range, 56.2% below the 52-week high.
- That makes 3 straight gains.
Oct 13, 2026 — NUS rises 2.9% to $5.01, a 1-month high
- Closed at $5.01, +2.87% vs the prior close of $4.87. Day range $4.88–$5.02, opened at $4.90.
- Volume was 492.90K shares, 0.9x its 50-day average of 560.76K.
- Price is +4.5% vs its 50-day average ($4.79) and -25.6% vs its 200-day average ($6.73).
- 52-week range $4.45–$11.67; today's close sits at 8% of that range, 57.1% below the 52-week high.
Oct 12, 2026 — NUS rises 2.7% to $4.87
- Closed at $4.87, +2.74% vs the prior close of $4.74. Day range $4.70–$4.92, opened at $4.74.
- Volume was 590.90K shares, 1.1x its 50-day average of 554.59K.
- Price is +1.6% vs its 50-day average ($4.80) and -27.9% vs its 200-day average ($6.76).
- 52-week range $4.45–$11.67; today's close sits at 6% of that range, 58.3% below the 52-week high.
Oct 9, 2026 — NUS dips 0.6% to $4.74
- Closed at $4.74, -0.63% vs the prior close of $4.77. Day range $4.73–$4.86, opened at $4.77.
- Volume was 327.30K shares, 0.6x its 50-day average of 553.98K — lighter than usual.
- Price is -1.3% vs its 50-day average ($4.80) and -30.1% vs its 200-day average ($6.78).
- 52-week range $4.45–$11.67; today's close sits at 4% of that range, 59.4% below the 52-week high.
Oct 8, 2026 — NUS dips 0.6% to $4.77
- Closed at $4.77, -0.63% vs the prior close of $4.80. Day range $4.71–$4.81, opened at $4.80.
- Volume was 571.40K shares, 1.0x its 50-day average of 551.41K.
- Price is -0.9% vs its 50-day average ($4.81) and -30.0% vs its 200-day average ($6.81).
- 52-week range $4.45–$11.67; today's close sits at 4% of that range, 59.1% below the 52-week high.
Oct 7, 2026 — NUS rises 1.3% to $4.80, 5 up days in a row
- Closed at $4.80, +1.27% vs the prior close of $4.74. Day range $4.69–$4.86, opened at $4.71.
- Volume was 482.70K shares, 0.9x its 50-day average of 554.30K.
- Price is -0.5% vs its 50-day average ($4.82) and -29.8% vs its 200-day average ($6.84).
- 52-week range $4.45–$11.67; today's close sits at 5% of that range, 58.9% below the 52-week high.
- That makes 5 straight gains.
Oct 6, 2026 — NUS rises 2.4% to $4.74, 4 up days in a row
- Closed at $4.74, +2.38% vs the prior close of $4.63. Day range $4.64–$4.80, opened at $4.67.
- Volume was 404.10K shares, 0.7x its 50-day average of 555.27K.
- Price is -1.9% vs its 50-day average ($4.83) and -30.9% vs its 200-day average ($6.86).
- 52-week range $4.45–$11.67; today's close sits at 4% of that range, 59.4% below the 52-week high.
- That makes 4 straight gains.
Oct 5, 2026 — NUS rises 0.4% to $4.63, 3 up days in a row
- Closed at $4.63, +0.43% vs the prior close of $4.61. Day range $4.54–$4.66, opened at $4.62.
- Volume was 458.90K shares, 0.8x its 50-day average of 553.95K.
- Price is -4.3% vs its 50-day average ($4.84) and -32.8% vs its 200-day average ($6.89).
- 52-week range $4.45–$12.03; today's close sits at 2% of that range, 61.5% below the 52-week high.
- That makes 3 straight gains.
Oct 2, 2026 — NUS rises 1.3% to $4.61
- Closed at $4.61, +1.32% vs the prior close of $4.55. Day range $4.52–$4.66, opened at $4.59.
- Volume was 376.40K shares, 0.7x its 50-day average of 557.23K.
- Price is -4.9% vs its 50-day average ($4.85) and -33.4% vs its 200-day average ($6.92).
- 52-week range $4.45–$12.04; today's close sits at 2% of that range, 61.7% below the 52-week high.
NUS latest news & SEC filings
Every SEC filing by or about NUS in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 10, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 21, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Aug 10, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $320.11M (prior year $386.14M) (-17.1% vs Jun 30, 2025)
- Net income: -$249.80M (prior year $21.12M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$5.14 (prior year $0.43) (loss widened vs Jun 30, 2025)
Aug 10, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Things to know before you trade NUS
- Last results release: Aug 10, 2026 (8-K Item 2.02). Previous ones: May 7, 2026, Feb 12, 2026, Nov 6, 2025. Based on that rhythm, the next report is likely around Nov 9, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.61% (largest 5.1%).
- Liquidity: about 480.26K shares (≈$2.47M) trade per day on average.
- 52-week position: $5.14 vs a range of $4.45–$11.67 (10% of the range).
- Dividends: last ex-dividend date Aug 28, 2026 ($0.06/share); 4 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 4 open-market buys, 12 sales; latest: James M Winett sold 7,203 shares on Jun 2, 2026.
- Latest filings: 8-K Aug 21, 2026; 10-Q Aug 10, 2026; 8-K Aug 10, 2026.
- Share count: 48.68M shares outstanding (Jul 31, 2026), -1.7% vs a year earlier.
- Listing: NYSE · industry: Wholesale-Drugs, Proprietaries & Druggists' Sundries.
NUS market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 5.24 | 5.39 | 5.11 | 5.14 | 572.31K |
| Oct 15, 2026 | 5.16 | 5.34 | 5.16 | 5.21 | 511.40K |
| Oct 14, 2026 | 5.03 | 5.12 | 4.99 | 5.11 | 421.40K |
| Oct 13, 2026 | 4.90 | 5.02 | 4.88 | 5.01 | 492.90K |
| Oct 12, 2026 | 4.74 | 4.92 | 4.70 | 4.87 | 590.90K |
| Oct 9, 2026 | 4.77 | 4.86 | 4.73 | 4.74 | 327.30K |
| Oct 8, 2026 | 4.80 | 4.81 | 4.71 | 4.77 | 571.40K |
| Oct 7, 2026 | 4.71 | 4.86 | 4.69 | 4.80 | 482.70K |
| Oct 6, 2026 | 4.67 | 4.80 | 4.64 | 4.74 | 404.10K |
| Oct 5, 2026 | 4.62 | 4.66 | 4.54 | 4.63 | 458.90K |
| Oct 2, 2026 | 4.59 | 4.66 | 4.52 | 4.61 | 376.40K |
| Oct 1, 2026 | 4.51 | 4.55 | 4.45 | 4.55 | 693.30K |
| Sep 30, 2026 | 4.63 | 4.65 | 4.49 | 4.53 | 720.90K |
| Sep 29, 2026 | 4.65 | 4.73 | 4.59 | 4.59 | 415.40K |
| Sep 28, 2026 | 4.62 | 4.70 | 4.58 | 4.64 | 317.10K |
| Sep 25, 2026 | 4.62 | 4.67 | 4.59 | 4.63 | 370.00K |
| Sep 24, 2026 | 4.63 | 4.70 | 4.56 | 4.62 | 428.90K |
| Sep 23, 2026 | 4.83 | 4.84 | 4.61 | 4.61 | 327.10K |
| Sep 22, 2026 | 4.74 | 4.88 | 4.74 | 4.86 | 508.00K |
| Sep 21, 2026 | 4.60 | 4.72 | 4.58 | 4.68 | 614.70K |
About Nu Skin Enterprises
Nu Skin Enterprises (NUS) is listed on the NYSE and classified by the SEC under “Wholesale-Drugs, Proprietaries & Druggists' Sundries”. Its business address is in PROVO, UT. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1021561.
NUS board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Emma S. Battle | Director | Jun 3, 2026 |
| Daniel W Campbell | Director | Jun 3, 2026 |
| Ryan S Napierski | President and CEO | Mar 9, 2026 |
| Laura Nathanson | Director | Jun 3, 2026 |
| Pisano R. Thomas | Director | Jun 3, 2026 |
| Edwina D Woodbury | Director | Sep 10, 2026 |
| James M Winett | Director | Jun 3, 2026 |
| Mark A Zorko | Director | Jun 3, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Chayce David Clark | EVP, COO and CLO | Mar 9, 2026 |
| Steven Keith Hatchett | Chief Product Officer | Mar 9, 2026 |
| Justin S Keisel | EVP, President of Global Sales | Mar 9, 2026 |
| Chelsea K Lantz | Chief Financial Officer | Mar 30, 2026 |
| Ryan S Napierski | President and CEO | Mar 9, 2026 |
| James D Thomas | Chief Financial Officer | Mar 9, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 2, 2026 | James M Winett | Sale | 7,203 | $5.62 |
| Jun 2, 2026 | James M Winett | Sale | 7,203 | $5.62 |
| Jun 2, 2026 | James M Winett | Sale | 7,203 | $5.62 |
| Jun 2, 2026 | James M Winett | Sale | 7,203 | $5.62 |
| Jun 1, 2026 | Edwina D Woodbury | Sale | 7,203 | $5.70 |
| Jun 1, 2026 | Edwina D Woodbury | Sale | 7,203 | $5.70 |
| Jun 1, 2026 | Edwina D Woodbury | Sale | 7,203 | $5.70 |
| Jun 1, 2026 | Edwina D Woodbury | Sale | 7,203 | $5.70 |
| May 11, 2026 | Laura Nathanson | Sale | 2,676 | $6.73 |
| May 11, 2026 | Laura Nathanson | Sale | 2,676 | $6.73 |
| May 11, 2026 | Laura Nathanson | Sale | 2,676 | $6.73 |
| May 11, 2026 | Laura Nathanson | Sale | 2,676 | $6.73 |
| Nov 11, 2025 | Steven Keith Hatchett | Buy | 5,500 | $9.61 |
| Nov 11, 2025 | Steven Keith Hatchett | Buy | 5,500 | $9.61 |
| Nov 11, 2025 | Steven Keith Hatchett | Buy | 5,500 | $9.61 |
NUS financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $1.49B | $160.20M | 3.18 | $80.29M |
| Dec 31, 2024 | $1.73B | $-146.59M | -2.95 | $111.74M |
| Dec 31, 2023 | $1.97B | $8.60M | 0.17 | $118.64M |
| Dec 31, 2022 | $2.23B | $104.78M | 2.07 | $108.06M |
| Dec 31, 2021 | $2.70B | $147.27M | 2.86 | $141.58M |
Latest balance sheet: total assets $1.12B, total liabilities $578.79M, cash $189.64M (as of Jun 30, 2026).
NUS earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 10, 2026 | 8-K Item 2.02 (results) | $5.15 |
| May 7, 2026 | 8-K Item 2.02 (results) | $7.02 |
| Feb 12, 2026 | 8-K Item 2.02 (results) | $10.21 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $10.83 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $8.20 |
| May 8, 2025 | 8-K Item 2.02 (results) | $6.16 |
| Feb 13, 2025 | 8-K Item 2.02 (results) | $6.42 |
| Jan 13, 2025 | 8-K Item 2.02 (results) | $6.83 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $6.45 |
| Aug 8, 2024 | 8-K Item 2.02 (results) | — |
| May 8, 2024 | 8-K Item 2.02 (results) | — |
| Feb 14, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Wholesale-Drugs, Proprietaries & Druggists' Sundries
Mckesson (MCK)Cardinal Health (CAH)Cencora (COR)DataMeds AI (MEDS)Herbalife (HLF)Cosmos Health (COSM)HWH International (ESYN)Cellyan Biotechnology (HKPD)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on NUS
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.